Age-related macular degeneration (AMD) is a condition that affects the macula of the retina and leads to vision loss in individuals over the age of 50. AMD is characterized by the deposition of colloid bodies, known as drusen, between the retinal pigment epithelium and Bruch’s membrane. The condition is more common with increasing age and is associated with risk factors such as smoking, hypermetropia, previous cataract surgery, high blood pressure, and genetic predisposition. Symptoms of AMD include difficulty with visual tasks, flashing lights, night glares, floaters, reduced night vision, and central vision loss. Diagnosis involves ruling out other eye disorders and conducting vision tests, refraction tests, slit-lamp examinations, optical coherence tomography (OCT), and fluorescein angiography. While there is no effective treatment for dry AMD, lifestyle changes, rehabilitation, laser photocoagulation, photodynamic therapy, and angiogenesis inhibitors like anti-VEGF agents can be used to manage wet AMD and minimize vision loss. Regular checkups and adopting a healthy lifestyle are also recommended for individuals with AMD.